{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:39:53Z","timestamp":1792633193473,"version":"4.5.0"},"reference-count":141,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Medicine"],"DOI":"10.1080\/17460751.2026.2751695","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:02:27Z","timestamp":1792630947000},"page":"1-21","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Engineering stem cell-derived islets for type 1 diabetes: genetic strategies for immune evasion and stress resilience"],"prefix":"10.1080","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1892-5565","authenticated-orcid":false,"given":"Caterra","family":"Leavens","sequence":"first","affiliation":[{"name":"University of Wisconsin-Madison, Clinical Science Center","place":["Madison, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4980-4347","authenticated-orcid":false,"given":"Connie S.","family":"Chamberlain","sequence":"additional","affiliation":[{"name":"University of Wisconsin-Madison, Clinical Science Center","place":["Madison, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deep","family":"Kapadia","sequence":"additional","affiliation":[{"name":"University of Wisconsin-Madison, Clinical Science Center","place":["Madison, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Jurrens","sequence":"additional","affiliation":[{"name":"University of Wisconsin-Madison, Clinical Science Center","place":["Madison, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esau","family":"Estrada","sequence":"additional","affiliation":[{"name":"University of Wisconsin-Madison, Clinical Science Center","place":["Madison, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Talerico","sequence":"additional","affiliation":[{"name":"University of Wisconsin-Madison, Clinical Science Center","place":["Madison, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makenna","family":"Arroyo","sequence":"additional","affiliation":[{"name":"University of Wisconsin-Madison, Clinical Science Center","place":["Madison, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palak","family":"Dhiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1096-464X","authenticated-orcid":false,"given":"Jon","family":"Odorico","sequence":"additional","affiliation":[{"name":"University of Wisconsin-Madison, Clinical Science Center","place":["Madison, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"e_1_3_6_3_1","unstructured":"The International Diabetes Federation (IDF): 2026 International Diabetes Federation. 2026 [cited 2026 Sep 19]. Available from: https:\/\/diabetesatlas.org\/data-by-indicator\/type-1-diabetes-estimates\/people-with-type-1-diabetes-all-age-groups\/"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112277"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02401-w"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.111011"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-016-8592-1"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a007682"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1734431"},{"issue":"10035","key":"e_1_3_6_10_1","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/S0140-6736(16)30582-7","article-title":"Genetic risk factors for type 1 diabetes","volume":"387","author":"Pociot F","year":"2016","unstructured":"Pociot F, Lernmark A. Genetic risk factors for type 1 diabetes. Lancet. 2016;387(10035):2331\u20132339.","journal-title":"Lancet"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2025.102183"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-00443-4"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101365"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1391504"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00310.2021"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2022.10817"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03767-8"},{"key":"e_1_3_6_18_1","unstructured":"Vertex announces positive results from ongoing phase 1\/2 study of VX-880 for the treatment of type 1 diabetes presented at the American Diabetes Association 84th scientific sessions [Internet]. 2024 [cited 2026 Sep 19] Available from: https:\/\/news.vrtx.com\/news-releases\/news-release-details\/vertex-announces-positive-results-ongoing-phase-12-study-vx-880"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2506549"},{"key":"e_1_3_6_20_1","unstructured":"Medicine NLo. A safety tolerability and efficacy study of VX-880 and VX-017 in participants with type 1 diabetes. U.S. National Library of Medicine; 2026 [cited 2026 Sep 19]. Available from: ClinicalTrials.gov NCT04786262."},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.09.004"},{"issue":"4","key":"e_1_3_6_22_1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S2213-8587(25)00423-1","article-title":"Autologous and allogeneic stem cell-derived islet therapy in three recipients with type 1 diabetes and complete loss of endogenous pancreatic beta-cell function pretransplant","volume":"14","author":"Shi Y","year":"2026","unstructured":"Shi Y, Feng Y, Li T, et al. Autologous and allogeneic stem cell-derived islet therapy in three recipients with type 1 diabetes and complete loss of endogenous pancreatic beta-cell function pretransplant. Lancet Diabetes Endocrinol. 2026;14(4):285\u2013288.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0001123172.68855.f9"},{"key":"e_1_3_6_24_1","unstructured":"Nicole Keith RA. Sana biotechnology announces positive clinical results from type 1 diabetes study of islet cell transplantation without immunosuppression 2025. [cited 2026 Sep 19]. Available from: https:\/\/www.breakthrought1d.org\/for-the-media\/press-releases\/sana-biotechnology-announces-positive-clinical-results-from-type-1-diabetes-study-of-islet-cell-transplantation-without-immunosuppression\/"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2503822"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2604408"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0016-3"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01784-x"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg5794"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2024.02.001"},{"key":"e_1_3_6_31_1","unstructured":"Eledon reports preliminary data from first six patients with type 1 diabetes treated with tegoprubart as the core immunosuppressant following islet transplantation in investigator-initiated trial at UChicago medicine [Internet]. Eledon Pharmaceuticals Inc.; 2025 [cited 2026 Sep 19]. Available from: https:\/\/ir.eledon.com\/news-releases\/news-release-details\/eledon-reports-preliminary-data-first-six-patients-type-1"},{"issue":"211","key":"e_1_3_6_32_1","doi-asserted-by":"crossref","first-page":"211ra156","DOI":"10.1126\/scitranslmed.3006534","article-title":"Restoration of the unfolded protein response in pancreatic beta cells protects mice against type 1 diabetes","volume":"5","author":"Engin F","year":"2013","unstructured":"Engin F, Yermalovich A, Nguyen T, et al. Restoration of the unfolded protein response in pancreatic beta cells protects mice against type 1 diabetes. Sci Transl Med. 2013;5(211):211ra156.","journal-title":"Sci Transl Med"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199212000-00025"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15322"},{"issue":"6","key":"e_1_3_6_35_1","doi-asserted-by":"crossref","first-page":"e2435","DOI":"10.1371\/journal.pone.0002435","article-title":"Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation","volume":"3","author":"Huurman VA","year":"2008","unstructured":"Huurman VA, Hilbrands R, Pinkse GG, et al. Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLOS ONE. 2008;3(6):e2435.","journal-title":"PLOS ONE"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0498"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00343"},{"issue":"37","key":"e_1_3_6_38_1","doi-asserted-by":"crossref","first-page":"eabn5732","DOI":"10.1126\/sciadv.abn5732","article-title":"Transcription and splicing regulation by NLRC5 shape the interferon response in human pancreatic beta cells","volume":"8","author":"Szymczak F","year":"2022","unstructured":"Szymczak F, Alvelos MI, Marin-Canas S, et al. Transcription and splicing regulation by NLRC5 shape the interferon response in human pancreatic beta cells. Sci Adv. 2022;8(37):eabn5732.","journal-title":"Sci Adv"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00582"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI35197"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1258"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31816b22f3"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1517\/03009734000000059"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-013-0401-0"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2021.03.018"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.59"},{"issue":"1","key":"e_1_3_6_47_1","doi-asserted-by":"crossref","first-page":"100879","DOI":"10.1016\/j.xcrm.2022.100879","article-title":"Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance","volume":"4","author":"Gerace D","year":"2023","unstructured":"Gerace D, Zhou Q, Kenty JH, et al. Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance. Cell Rep Med. 2023;4(1):100879.","journal-title":"Cell Rep Med"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.14.1.301"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201445378"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.2337\/db07-1260"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2013.11.014"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.707881"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.989815"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000055"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.200348397"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2008.05.005"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-014-0282-0"},{"issue":"4","key":"e_1_3_6_58_1","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4049\/jimmunol.1301828","article-title":"IDO-independent suppression of T cell effector function by IFN-gamma-licensed human mesenchymal stromal cells","volume":"192","author":"Chinnadurai R","year":"2014","unstructured":"Chinnadurai R, Copland IB, Patel SR, et al. IDO-independent suppression of T cell effector function by IFN-gamma-licensed human mesenchymal stromal cells. J Immunol. 2014;192(4):1491\u20131501.","journal-title":"J Immunol"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.17162"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-0135-0_3"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3860"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI43522"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13770-025-00742-9"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-025-06409-3"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1121623109"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004589"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62568-2"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14847-7"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/88720"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2012.00179"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103414"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.176084"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/346751a0"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.regen.2021.100057"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199403270-00001"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916939008995731"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103136"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2023.07.023"},{"issue":"35","key":"e_1_3_6_79_1","doi-asserted-by":"crossref","first-page":"eaba5573","DOI":"10.1126\/sciadv.aba5573","article-title":"Immunotherapy via PD-L1-presenting biomaterials leads to long-term islet graft survival","volume":"6","author":"Coronel MM","year":"2020","unstructured":"Coronel MM, Martin KE, Hunckler MD, et al. Immunotherapy via PD-L1-presenting biomaterials leads to long-term islet graft survival. Sci Adv. 2020;6(35):eaba5573.","journal-title":"Sci Adv"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(05)80055-8"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300830"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13434"},{"issue":"4","key":"e_1_3_6_83_1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41551-023-01133-y","article-title":"Immune-privileged tissues formed from immunologically cloaked mouse embryonic stem cells survive long term in allogeneic hosts","volume":"8","author":"Harding J","year":"2024","unstructured":"Harding J, Vintersten-Nagy K, Yang H, et al. Immune-privileged tissues formed from immunologically cloaked mouse embryonic stem cells survive long term in allogeneic hosts. Nat Biomed Eng. 2024;8(4):427\u2013442.","journal-title":"Nat Biomed Eng"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12946"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0200-1"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2014.55"},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05669-7"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2022.01.018"},{"key":"e_1_3_6_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.03.002"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9020156"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002277"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099684"},{"key":"e_1_3_6_93_1","doi-asserted-by":"publisher","DOI":"10.2337\/db09-1064"},{"key":"e_1_3_6_94_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176136"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.101949"},{"key":"e_1_3_6_96_1","doi-asserted-by":"publisher","DOI":"10.2337\/db19-322-LB"},{"issue":"10","key":"e_1_3_6_97_1","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1172\/JCI79264","article-title":"Insulin demand regulates beta cell number via the unfolded protein response","volume":"125","author":"Sharma RB","year":"2015","unstructured":"Sharma RB, O\u2019Donnell AC, Stamateris RE, et al. Insulin demand regulates beta cell number via the unfolded protein response. J Clin Invest. 2015;125(10):3831\u20133846.","journal-title":"J Clin Invest"},{"key":"e_1_3_6_98_1","doi-asserted-by":"publisher","DOI":"10.2337\/db26-0048"},{"key":"e_1_3_6_99_1","doi-asserted-by":"publisher","DOI":"10.3390\/epigenomes8010010"},{"key":"e_1_3_6_100_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102432"},{"key":"e_1_3_6_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.10.014"},{"key":"e_1_3_6_102_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1212716"},{"key":"e_1_3_6_103_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1196460"},{"issue":"6814","key":"e_1_3_6_104_1","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/35048589","article-title":"Attenuation of FGF signalling in mouse beta-cells leads to diabetes","volume":"408","author":"Hart AW","year":"2000","unstructured":"Hart AW, Baeza N, Apelqvist A, et al. Attenuation of FGF signalling in mouse beta-cells leads to diabetes. Nature. 2000;408(6814):864\u2013868.","journal-title":"Nature"},{"key":"e_1_3_6_105_1","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae118"},{"key":"e_1_3_6_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2025.103469"},{"key":"e_1_3_6_107_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126866"},{"issue":"2","key":"e_1_3_6_108_1","doi-asserted-by":"crossref","first-page":"105631","DOI":"10.1016\/j.jbc.2024.105631","article-title":"PTP1B mediates the inhibitory effect of MFGE8 on insulin signaling through the beta5 integrin","volume":"300","author":"Datta R","year":"2024","unstructured":"Datta R, Mukherjee D, Podolsky MJ, et al. PTP1B mediates the inhibitory effect of MFGE8 on insulin signaling through the beta5 integrin. J Biol Chem. 2024;300(2):105631.","journal-title":"J Biol Chem"},{"key":"e_1_3_6_109_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006812218502"},{"key":"e_1_3_6_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-015-2220-x"},{"key":"e_1_3_6_111_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells12040565"},{"key":"e_1_3_6_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107151"},{"key":"e_1_3_6_113_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.128820"},{"key":"e_1_3_6_114_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202405175"},{"key":"e_1_3_6_115_1","doi-asserted-by":"publisher","DOI":"10.2337\/db23-0030"},{"key":"e_1_3_6_116_1","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-0254-1"},{"key":"e_1_3_6_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2025.102115"},{"key":"e_1_3_6_118_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.08-111690"},{"key":"e_1_3_6_119_1","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12836"},{"key":"e_1_3_6_120_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-025-04314-5"},{"key":"e_1_3_6_121_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-29"},{"key":"e_1_3_6_122_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M701890200"},{"key":"e_1_3_6_123_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05703-8"},{"key":"e_1_3_6_124_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01886-1"},{"key":"e_1_3_6_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2007.01.003"},{"key":"e_1_3_6_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2022.09.005"},{"key":"e_1_3_6_127_1","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15007"},{"key":"e_1_3_6_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)93015-2"},{"key":"e_1_3_6_129_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211111"},{"key":"e_1_3_6_130_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1759835"},{"key":"e_1_3_6_131_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr229"},{"key":"e_1_3_6_132_1","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13449"},{"key":"e_1_3_6_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2006.10.008"},{"key":"e_1_3_6_134_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.999108"},{"key":"e_1_3_6_135_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00523.2012"},{"key":"e_1_3_6_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lddd.2025.100146"},{"key":"e_1_3_6_137_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.66670"},{"key":"e_1_3_6_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2024.105769"},{"key":"e_1_3_6_139_1","unstructured":"Administration USFaD. Human gene therapy products incorporating human genome editing: U.S. Food and Drug Administration. 2024 [updated January 2024; cited 2026 Sep 19th]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/human-gene-therapy-products-incorporating-human-genome-editing"},{"key":"e_1_3_6_140_1","unstructured":"Administration USFaD. Safety assessment of genome editing in human gene therapy products using next-generation sequencing: U.S. Food and Drug Administration. 2026 [updated April 2026; cited 2026 Sep 19th]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/safety-assessment-genome-editing-human-gene-therapy-products-using-next-generation-sequencing"},{"key":"e_1_3_6_141_1","volume-title":"Genetic safety switches for pluripotent stem cell-derived therapies for diabetes","author":"Cohen DE","year":"2023","unstructured":"Cohen DE, Odorico JS. Genetic safety switches for pluripotent stem cell-derived therapies for diabetes. Cham: Springer; 2023."},{"key":"e_1_3_6_142_1","unstructured":"Administration USFaD. Potency assurance for cellular and gene therapy products: U.S. Food and Drug Administration. 2023 [updated December 2023; cited 2026 Sep 19th]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/potency-assurance-cellular-and-gene-therapy-products"},{"key":"e_1_3_6_143_1","unstructured":"Administration USFaD. Long term follow-up after administration of human gene therapy products: U.S. Food and Drug Administration. 2020 [cited 2026 Sep 19th]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/long-term-follow-after-administration-human-gene-therapy-products"}],"container-title":["Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17460751.2026.2751695","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17460751.2026.2751695","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17460751.2026.2751695","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:02:31Z","timestamp":1792630951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17460751.2026.2751695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":141,"alternative-id":["10.1080\/17460751.2026.2751695"],"URL":"https:\/\/doi.org\/10.1080\/17460751.2026.2751695","relation":{},"ISSN":["1746-0751","1746-076X"],"issn-type":[{"value":"1746-0751","type":"print"},{"value":"1746-076X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=irme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=irme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-07-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}